1 active not recruiting, 1 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Recurrent Cutaneous Melanoma: new trials by email Literature Review of Recurrent Cutaneous Melanoma trials Research Report on Recurrent Cutaneous Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 60 | 2021-10-15 | 2026-09-29 |
| Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement Binimetinib, Conventional Surgery, Encorafenib - Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node | Phase 2 | Terminated | ECOG-ACRIN Cancer Research Group | 3 | 2021-09-22 | 2026-10-06 |
| Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma Ibrutinib, Laboratory Biomarker Analysis, Pharmacogenomic Study - Metastatic Melanoma, Recurrent Cutaneous Melanoma | Phase 2 | Completed | National Cancer Institute (NCI) | 18 | 2016-12-16 | 2026-08-11 |
Melanoma (3) · Lymphatic Metastasis (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3) · Nevi and Melanomas (3) · Skin Diseases (3) · Skin Neoplasms (3) · Skin and Connective Tissue Diseases (3) · Neoplasm Metastasis (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Biopsy (1) · Magnetic Resonance Spectroscopy (1) · Pharmacogenomic Testing (1) · Specimen Handling (1) · Surgical Procedures, Operative (1) · alovudine (1) · binimetinib (1) · encorafenib (1) · ibrutinib (1) · pembrolizumab (1)
National Cancer Institute (NCI) (2) · ECOG-ACRIN Cancer Research Group (1)
United States (3)
Ahmad Tarhini (1) · Leslie A Fecher (1) · Stergios J Moschos (1)
U10CA180820 (2), UM1CA186644 (1), UM1CA186686 (1), UM1CA186688 (1), UM1CA186689 (1), UM1CA186690 (1), UM1CA186691 (1), UM1CA186704 (1), UM1CA186709 (1), UM1CA186712 (1), UM1CA186716 (1), UM1CA186717 (1)